Overview of external reference pricing systems in Europe.

ABSTRACT:

Background and objectives

External reference pricing (ERP) is a price regulation tool widely used by policy makers in the European Union (EU) Member States (MS) to contain drug cost, although in theory, it may contribute to modulate prices up and down. The objective of this article was to summarise and discuss the main findings of part of a large project conducted for the European Commission ('External reference pricing of medicinal products: simulation-based considerations for cross-country coordination'; see www.ec.europa.eu/health/healthcare/docs/erp_reimbursement_medicinal_products_en.pdf) that aimed to provide an overview of ERP systems, both on processes and potential issues in 31 European countries (28 EU MS, Iceland, Norway, and Switzerland).

Methods

A systematic str

SUBMITTER: Remuzat C 

PROVIDER: S-EPMC4802694 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature